These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2051 related items for PubMed ID: 17240920

  • 21. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C.
    Vaccine; 2012 Mar 23; 30(14):2490-7. PubMed ID: 21704108
    [Abstract] [Full Text] [Related]

  • 24. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J, Tang Q, Yu F, Yang H, Zhao F, Xu W, Wang J, Hu W, Hu K, Liou C, Feng He X, Wang Y.
    Immunobiology; 2010 Mar 23; 215(2):133-42. PubMed ID: 19450898
    [Abstract] [Full Text] [Related]

  • 25. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Matsumoto M, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Mar 23; 7 Suppl():60-7. PubMed ID: 21546794
    [Abstract] [Full Text] [Related]

  • 26. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I, Udagawa T, Taniyama T.
    Tuberculosis (Edinb); 2007 Mar 23; 87(2):94-101. PubMed ID: 16815096
    [Abstract] [Full Text] [Related]

  • 27. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C, Derrick SC, Yang AL, Jeon BY, Morris SL.
    Vaccine; 2006 Apr 24; 24(17):3522-9. PubMed ID: 16519971
    [Abstract] [Full Text] [Related]

  • 28. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
    Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, Agger EM, Aagaard C, Weiler H, van Soolingen D, Dalemans W, Thomas AW, Andersen P.
    Vaccine; 2005 Apr 15; 23(21):2740-50. PubMed ID: 15780721
    [Abstract] [Full Text] [Related]

  • 29. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M.
    Procedia Vaccinol; 2010 Apr 15; 2(1):34-39. PubMed ID: 32288910
    [Abstract] [Full Text] [Related]

  • 30. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
    Li H, Li R, Zhong S, Ren H, Zou Y, Chen X, Shi X, Wang M, Long H, Luo Y.
    Vaccine; 2006 Feb 27; 24(9):1315-23. PubMed ID: 16219397
    [Abstract] [Full Text] [Related]

  • 31. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X, Gao Q, Fu R.
    Scand J Immunol; 2007 Nov 27; 66(5):523-8. PubMed ID: 17916110
    [Abstract] [Full Text] [Related]

  • 32. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC.
    Vaccine; 2009 Jul 16; 27(33):4412-23. PubMed ID: 19500523
    [Abstract] [Full Text] [Related]

  • 33. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN, Allen SS, Jeevan A, Lasco T, Cho H, Skwor T, Yamamoto T, McFarland C, Yoshimura T.
    Tuberculosis (Edinb); 2005 Jul 16; 85(5-6):295-301. PubMed ID: 16253558
    [Abstract] [Full Text] [Related]

  • 34. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H, Li K, Yu S, Xiong S.
    Microbiol Immunol; 2009 Oct 16; 53(10):541-9. PubMed ID: 19780967
    [Abstract] [Full Text] [Related]

  • 35. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H, Peng P, Miao S, Zhao Y, Mao F, Wang L, Bai Y, Xu Z, Wei S, Shi C.
    Scand J Immunol; 2010 Oct 16; 72(4):349-57. PubMed ID: 20883320
    [Abstract] [Full Text] [Related]

  • 36. [The estimation of protective efficacy of the fusion gene vaccine encoding tubercle antigen 85B and MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Jiang S, Chen Q, Jiang Y.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 17; 84(8):687-91. PubMed ID: 15130316
    [Abstract] [Full Text] [Related]

  • 37. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.
    Yu DH, Li M, Hu XD, Cai H.
    Vaccine; 2007 Sep 17; 25(37-38):6744-54. PubMed ID: 17681650
    [Abstract] [Full Text] [Related]

  • 38. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.
    Maue AC, Waters WR, Palmer MV, Nonnecke BJ, Minion FC, Brown WC, Norimine J, Foote MR, Scherer CF, Estes DM.
    Vaccine; 2007 Jun 11; 25(24):4735-46. PubMed ID: 17499400
    [Abstract] [Full Text] [Related]

  • 39. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J, Vipond R, Allen-Vercoe E, Clark SO, Hatch GJ, Gooch KE, Bacon J, Hampshire T, Shuttleworth H, Minton NP, Blake K, Williams A, Marsh PD.
    Vaccine; 2006 Sep 11; 24(37-39):6340-50. PubMed ID: 16781800
    [Abstract] [Full Text] [Related]

  • 40. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ, Kursar M, Kaufmann SH.
    J Infect Dis; 2004 Aug 01; 190(3):588-97. PubMed ID: 15243936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 103.